stockrowHaemonetics Corporation
HAE Healthcare Medical Devices
Haemonetics Corporation’s revenue for fiscal 2026 (year ended March 2026) was $1.3 billion, down 1.97% from fiscal 2025.
- Revenue
- +9.30%
- EPS
- +25.9%
- Free cash flow
- +20.4%
- Total debt
- +21.0%
Quarter to September 2026, against a year earlier
Follow HAE
Alert me
Haemonetics Corporation (HAE) Total debt
Haemonetics Corporation's total debt at the end of fiscal 2026 was $1.2B, up 32.4% from $921.2M in fiscal 2025. At the end of the quarter to 30 September 2026 it was $1.1B. Over the past ten years it has ranged from $59.4M (fiscal 2018) to $1.2B (fiscal 2026) — the current reading is the highest in ten years. Haemonetics Corporation ranks 19th of 147 Medical Devices companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2026 | $1.2B | 32.38% |
| FY2025 | $921.2M | 15.51% |
| FY2024 | $797.6M | 5.76% |
| FY2023 | $754.1M | 34.80% |
| FY2022 | $559.4M | (18.99%) |
| FY2021 | $690.6M | 126.04% |
| FY2020 | $305.5M | (5.25%) |
| FY2019 | $322.5M | 442.64% |
| FY2018 | $59.4M | (76.57%) |
| FY2017 | $253.6M | (30.42%) |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $1.1B | (4.71%) |
| Jun 2026 | $1.2B | (4.13%) |
| Mar 2026 | $1.2B | 32.56% |
| Dec 2025 | $920.0M | (0.04%) |
| 43 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| BRKR Bruker Corporation compare | $1.7B |
| ITGR Integer Holdings Corporation compare | $1.3B |
| BIO.B Bio-Rad Laboratories, Inc. compare | $1.2B |
| BIO Bio-Rad Laboratories, Inc. compare | $1.2B |
| HAE Haemonetics Corporation | $1.1B |
| IRTC iRhythm Holdings, Inc. compare | $651.9M |
| LIVN LivaNova PLC compare | $299.1M |
| TXG 10x Genomics compare | $98.0M |
| AXGN AxoGen, Inc. compare | $17.6M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on HAE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement